Soleno Therapeutics (SLNO) had its price target lowered by HC Wainwright from $120.00 to $100.00. They now have a "buy" rating on the stock.
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy [Yahoo! Finance]
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 – Here's Why [Yahoo! Finance]
Soleno Profitability Milestone And CFO Shift Raise Valuation Questions [Yahoo! Finance]
Soleno Therapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]